Showing results (41-50 of 220) with videos related to
Sort By:
Pageof 22
Peptides|January 1, 1994
Measurement of angiotensin II: use of two injectors to minimize HPLC shadowingG O Naik, C Forster, P W ArmstrongCardiovascular Research|June 1, 1991
Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failureR J Howard, G W Moe, P W ArmstrongJournal of Pharmaceutical and Biomedical Analysis|March 15, 2001
Specific and non-specific measurements of tissue angiotensin II cascade membersG O Naik, G W Moe, P W ArmstrongBritish Journal of Clinical Pharmacology|October 1, 1983
Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failureP W Armstrong, D G Watts, J A MoffatCirculation|December 1, 1982
Arterial-venous nitroglycerin gradient during intravenous infusion in manP W Armstrong, J A Moffat, G S MarksThe Canadian Journal of Cardiology|April 1, 1991
Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humansF J Brennan, J F Brien, P W ArmstrongThe American Journal of Medicine|June 1, 1980
Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunctionA J Leach, J E Brown, P W ArmstrongCardiovascular Research|March 1, 1993
Beta adrenoceptor recovery after heart failure in the dogG Larosa, P W Armstrong, P Seeman, et al.Journal of Cardiovascular Pharmacology|May 1, 1992
Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failureG W Moe, R Canepa-Anson, P W ArmstrongJournal of Cardiac Failure|April 22, 2004
Therapeutic exercise for individuals with heart failure: special attention to older women with heart failureM J Haykowsky, J A Ezekowitz, P W ArmstrongPageof 22